Revolve Biotechnologies is Drug Discovery in United States that focus on evolution platform business. Founded in 2013. They cover business area such as developer, a protein, nucleic acid evolution platform, custom dna library, a pipeline, protein product, development, healthcare researcher, high-affinity antibody, diagnostic and therapeutic application, oncolytic cancer therapeutic, infrare fluorescent protein, live deep-tissue imaging.
2013
( 11 years old in 2024 )
Evolution Platform
-
2401 West Belvedere Avenue
Schapiro 203
Baltimore, MD 21215
United States
Private
developera proteinnucleic acid evolution platformcustom dna librarya pipelineprotein productdevelopmenthealthcare researcherhigh-affinity antibodydiagnostic and therapeutic applicationoncolytic cancer therapeuticinfrare fluorescent proteinlive deep-tissue imaging
* We use standard office opening hours in near Revolve Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Revolve Biotechnologies is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), Revolve Biotechnologies business is focusing on Evolution Platform.
Revolve Biotechnologies headquarter office and corporate office address is located in 2401 West Belvedere Avenue Schapiro 203 Baltimore, MD 21215 United States.
Revolve Biotechnologies was founded in United States.
In 2024, Revolve Biotechnologies is currently focus on evolution platform sector.
Above is snippet of Google Trends for "evolution platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Revolve Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
